Community-acquired pneumonia--which patients are hospitalised? 2001

S P Stäuble, and S Reichlin, and T Dieterle, and B Leimenstoll, and R Schoenenberger, and B Martina
Department of Internal Medicine, University Hospital, Basel, Switzerland.

OBJECTIVE Patients with community-acquired pneumonia can be allocated into low and high-risk mortality groups by simple clinical criteria. We studied the value of the stratification for outcome as proposed by Fine, et al. to guide the decision for in-hospital versus outpatient treatment in the emergency department. METHODS We studied demographic data, risk group stratification and decision-making for in-hospital versus outpatient treatment in 101 consecutive medical emergency department patients with community-acquired pneumonia. We also analysed predictive factors for hospitalisation of low-risk patients. We obtained complete 30 day follow-up information. RESULTS Forty-three of 44 high-risk patients were hospitalised after medical emergency department triage. Twenty-seven (47%) of 57 low-risk patients were hospitalised as well. Based on routine clinical assessment, hospitalisation of low-risk patients was required for poor medical condition or severe pneumonia (67%), for lack of social support (15%) and for relevant comorbidity (18%). In an univariate analysis, age (p = 0.003), C-reactive protein (p = 0.0006), presence of comorbidity (p = 0.0001), Charlson index (p = 0.0001) and active oral steroid treatment (p = 0.028) were significantly correlated with hospitalisation of low-risk patients. The 30-day mortality rate was 32% in patients allocated to the high-risk group at the time of diagnosis in the emergency department, compared to 0% in low-risk patients. CONCLUSIONS Simple clinical criteria distinguish well between low and high 30-day-mortality risk in patients diagnosed with community-acquired pneumonia. Nevertheless, 47% of low-risk patients require in-hospital treatment. Age, C-reactive protein, presence of comorbidity and steroid treatment are significantly correlated with hospitalisation of low-risk patients with community-acquired pneumonia.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D005260 Female Females
D006760 Hospitalization The confinement of a patient in a hospital. Hospitalizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor

Related Publications

S P Stäuble, and S Reichlin, and T Dieterle, and B Leimenstoll, and R Schoenenberger, and B Martina
April 2006, The European respiratory journal,
S P Stäuble, and S Reichlin, and T Dieterle, and B Leimenstoll, and R Schoenenberger, and B Martina
January 2001, International journal of antimicrobial agents,
S P Stäuble, and S Reichlin, and T Dieterle, and B Leimenstoll, and R Schoenenberger, and B Martina
November 1999, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
S P Stäuble, and S Reichlin, and T Dieterle, and B Leimenstoll, and R Schoenenberger, and B Martina
January 2002, Drugs,
S P Stäuble, and S Reichlin, and T Dieterle, and B Leimenstoll, and R Schoenenberger, and B Martina
October 2014, Inflammation,
S P Stäuble, and S Reichlin, and T Dieterle, and B Leimenstoll, and R Schoenenberger, and B Martina
September 2004, Respiratory medicine,
S P Stäuble, and S Reichlin, and T Dieterle, and B Leimenstoll, and R Schoenenberger, and B Martina
September 2013, The European respiratory journal,
S P Stäuble, and S Reichlin, and T Dieterle, and B Leimenstoll, and R Schoenenberger, and B Martina
April 2012, The European respiratory journal,
S P Stäuble, and S Reichlin, and T Dieterle, and B Leimenstoll, and R Schoenenberger, and B Martina
July 2010, The European respiratory journal,
S P Stäuble, and S Reichlin, and T Dieterle, and B Leimenstoll, and R Schoenenberger, and B Martina
October 1994, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
Copied contents to your clipboard!